
Arkema S.A (AKE) | Stock Overview & Key Data
Arkema S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €134.95 on January 17, 2022
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Arkema S.A AKE | 4.64B Large-cap | 2.67% | 0.16% | -5.17% | -23.41% | -14.11% | -22.20% | -32.57% | -33.76% |
Explosifs Produits EXPL | 418.40M Mid-cap | 0.26% | -1.75% | -9.38% | -5.53% | 3.69% | 37.41% | 204.65% | 299.07% |
Lhyfe S.A.S LHYFE | 154.54M Mid-cap | 0.31% | -7.23% | -6.41% | -7.23% | 7.72% | -19.80% | -60.64% | -62.96% |
Carbios S.A ALCRB | 146.03M Small-cap | -2.00% | 16.62% | 23.52% | 23.34% | 15.17% | -59.76% | -73.94% | -68.43% |
Afyn SAS ALAFY | 66.17M Small-cap | 8.97% | -0.78% | 56.44% | 42.46% | 7.59% | -6.25% | -61.48% | -66.88% |
Vinpai S.A.S ALVIN | 12.08M Small-cap | -0.57% | 0.58% | 2.37% | 6.46% | 16.11% | -19.16% | -45.85% | -45.85% |
Ownership & Short Interest
Arkema S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Arkema S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is AKE's 52-week high and low?
- In the last 52 weeks, Arkema S.A reached a high of €88.40 (on September 27, 2024) and a low of €56.90 (on August 4, 2025).
- What is the market cap and P/E ratio for AKE?
- Curious about Arkema S.A's size and valuation? Its market capitalization stands at 4.64B. When it comes to valuation, the P/E ratio (trailing twelve months) is 24.40, and the forward P/E (looking ahead) is 6.31.
- Does AKE pay dividends? If so, what's the yield?
- As for dividends, Arkema S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Arkema S.A's main competitors or similar companies to consider before investing?
When looking at Arkema S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Explosifs Produits
EXPL418.40M Basic Materials Specialty Chemicals 37.41% 204.65% Lhyfe S.A.S
LHYFE154.54M Basic Materials Specialty Chemicals -19.80% -60.64% Carbios S.A
ALCRB146.03M Basic Materials Specialty Chemicals -59.76% -73.94% Afyn SAS
ALAFY66.17M Basic Materials Specialty Chemicals -6.25% -61.48% Vinpai S.A.S
ALVIN12.08M Basic Materials Specialty Chemicals -19.16% -45.85% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Arkema S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Arkema S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 2.93%, the Debt to Equity ratio from the most recent quarter is 50.89, and its Gross Profit Margin stands at 19.00%.
- What is the recent revenue and earnings growth for AKE?
- Looking at Arkema S.A's growth, its revenue over the trailing twelve months (TTM) was €9B. Compared to the same quarter last year (YoY), quarterly revenue grew by -5.60%, and quarterly earnings saw a YoY growth of -67.60%.
- How much of AKE stock is held by insiders and institutions?
- Wondering who owns Arkema S.A stock? Company insiders (like executives and directors) hold about 9.72% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 57.95%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.